Pooja Shah

Khawaja H, Sanders TA, Schreiber MD, Bondi DS, Shah PA, Brennan GM. Sildenafil as bridge therapy for inhaled nitric oxide in preterm neonates. J Pediatr Pharmacol Ther. In Press. (Accepted May 2023).

Wilson GA, Bondi DS, Shah PA, Nelson A, Kumar M, Bhagat PH. Neonatal Serum Gentamicin Concentrations and Outcomes Following Maternal Once-Daily Gentamicin Dosing. J Pediatr Pharmacol Ther. Accepted Aug 2022. 

Kleespies MS, Shah PA, Bondi DS. Use of Calcitonin for Hypercalcemia in a Premature Neonate with Congenital Mesoblastic Nephroma. J Pediatr Pharmacol Ther. Accepted Jan 2022. 

Galura G, Said SJ, Shah PA, Hissong AM, Chokshi NK, Fauman KR, Rose R, Bondi DS. Comparison of Extracorporeal Life Support Anticoagulation Using Activating Clotting Time Only to a Multimodal Approach in Pediatric Patients. J Pediatr Pharmacol Ther. 2022;27(6): 517-523. doi:10.5863/155106776-27.6.517. 

Naveed M, Bondi DS, Shah PA. Dexmedetomidine Versus Fentanyl for Neonates With Hypoxic Ischemic Encephalopathy Undergoing Therapeutic Hypothermia. J Pediatr Pharmacol Ther. 2022;27(4):352-357. doi: 10.5863/1551-6776-27.4.352. 

Hussain WA, Bondi DS, Shah P, Morgan SE, Sriram S, Schreiber MD. Implementation of an Inhaled Nitric Oxide Weaning Protocol and Stewardship in a Level 4 NICU to Decrease Inappropriate Use. J Pediatr Pharmacol Ther. 2022;27(3):284-291. doi: 10.5863/1551-6776-27.3.284. 

Pan I, Shah PA, Singh J, Kelly KN, Bondi DS. Comparison of neonatal outcomes with and without prophylaxis with indomethacin in premature neonates. J Pediatric Pharmacol Ther. Accepted Oct. 2020. DOI: 10.5863/1551-6776-26.5.478. 

Weaver KL, Bondi DS, Shah PA, Bhagat PH. Evaluation of appropriateness and cost-savings of pharmacist-driven palivizumab ordering. J Pediatr Pharmacol Ther. 2020;25(7): 636-641. DOI: 10.5863/1551-6776-25.7.636